Amgen

4 Cash-Heavy Large Cap Biotech Stocks That Analysts Rate As Buy
Seeking Alpha
Sat, 08/18/12 - 03:34 pm
Amgen
Celgene
Alexion
Regeneron
Pfizer's Success With Its JAK Inhibitor
Seeking Alpha
Fri, 08/17/12 - 10:18 am
Pfizer
JAK inhibitors
Abbott Laboratories
Amgen
Bristol-Myers Squibb
tofacitinib
rheumatoid arthritis
Will New RA Therapies Cause a Paradigm Shift?
Pharma Live
Tue, 08/14/12 - 02:25 pm
TNF blockers
rheumatoid arthritis
Humira
Abbott Laboratories
Pfizer
JAK inhibitors
tofacitinib
Amgen
Embrel
Remicade
JNJ
Amgen Ends Ganitumab Study on Panel Recommendation
NASDAQ.com
Thu, 08/9/12 - 11:34 am
Ganitumab
Amgen
pancreatic cancer
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Wed, 08/8/12 - 12:04 pm
Pluristem
Amgen
AstraZeneca
Celgene
Dendreon
Eli Lilly
Medivation
Merck
Onyx
Pfizer
bone marrow disorder
Amgen Inc (AMGN): Today's Featured Health Care Winner
The Steet
Sat, 08/4/12 - 11:13 am
Amgen
6 Healthcare Stocks With Pending August Catalysts
Seeking Alpha
Wed, 08/1/12 - 10:08 am
Abbott Labs
Amgen
Amarin
Arena Pharmaceuticals
Gilead
JNJ
Pfizer
Horizon Pharma
Vivus
Regeneron
Sanofi
Talon Therapeutics
Rigel's Drug Trials Offer Upside Through 2013
Seeking Alpha
Tue, 07/31/12 - 07:09 pm
Rigel Pharmaceuticals
Abbott Labs
Amgen
AstraZeneca
Biotechs In Motion As New Drug Pipeline Brims
investors.com
Sun, 07/29/12 - 01:00 pm
Amgen
Celgene
Biogen Idec
Gilead Sciences
Regeneron
Vertex Pharmaceuticals
Alexion
Arena Pharmaceuticals
ONYX Pharmaceuticals
United Therapeutics
Pay Attention to These Biotechs
Yahoo/TheStreet.com
Fri, 07/27/12 - 12:50 pm
Gilead
Amgen
Celgene
Amgen, Gilead Pop After Quarterly Earnings Beats
Investors.com
Fri, 07/27/12 - 11:41 am
earnings
Amgen
Gilead
Amgen Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Mon, 07/23/12 - 10:39 pm
Amgen
earnings
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Can Array BioPharma's Breakout Run Hold Or Continue?
Seeking Alpha
Mon, 07/23/12 - 08:53 am
Array Biopharma
Amgen
The Market Has Already Discounted Merck's New Drug
Seeking Alpha
Fri, 07/20/12 - 09:30 am
Merck
Abbott Labs
Amgen
GSK
Pfizer
Eli Lilly
osteoporosis
Odanacatib
Roche’s Secret Heart Drug Moves Toward Late-Stage Trial
Bloomberg
Fri, 07/20/12 - 09:29 am
Roche
Sanofi
PCSK9 inhibitor
Regeneron
Amgen
Alnylam Far From Primetime, But Still An Intriguing Prospect
Seeking Alpha
Mon, 07/9/12 - 05:19 pm
Alnylam
Isis
Regeneron
Amgen
Amgen closes $315M buyout of KAI Pharmaceuticals
Yahoo/AP
Thu, 07/5/12 - 05:24 pm
Amgen
M&A
KAI Pharmaceuticals
DaVita agrees to pay $55 million to settle suit over Epogen overuse
Yahoo/AP
Thu, 07/5/12 - 01:20 pm
anemia
DaVita
Epogen
dialysis
Amgen
Melanoma Treatments Look To Benefit From Large Market
Seeking Alpha
Tue, 07/3/12 - 11:46 am
Amgen
Bristol-Myers Squibb
GSK
OncoSec
Vical

Pages